Logo image of STI

SOLIDION TECHNOLOGY INC (STI) Stock Fundamental Analysis

NASDAQ:STI - Nasdaq - US8342121022 - Common Stock - Currency: USD

3.5  +0.01 (+0.29%)

After market: 3.4 -0.1 (-2.86%)

Fundamental Rating

0

Taking everything into account, STI scores 0 out of 10 in our fundamental rating. STI was compared to 94 industry peers in the Electrical Equipment industry. STI has a bad profitability rating. Also its financial health evaluation is rather negative. STI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

STI had negative earnings in the past year.
In the past year STI has reported a negative cash flow from operations.
STI Yearly Net Income VS EBIT VS OCF VS FCFSTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -5M -10M -15M -20M -25M

1.2 Ratios

With a Return On Assets value of -325.91%, STI is not doing good in the industry: 94.68% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -325.91%
ROE N/A
ROIC N/A
ROA(3y)-117.72%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STI Yearly ROA, ROE, ROICSTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for STI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STI Yearly Profit, Operating, Gross MarginsSTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for STI has been reduced compared to 1 year ago.
STI has a worse debt/assets ratio than last year.
STI Yearly Shares OutstandingSTI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M
STI Yearly Total Debt VS Total AssetsSTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -29.79, we must say that STI is in the distress zone and has some risk of bankruptcy.
STI has a worse Altman-Z score (-29.79) than 91.49% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -29.79
ROIC/WACCN/A
WACCN/A
STI Yearly LT Debt VS Equity VS FCFSTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.13 indicates that STI may have some problems paying its short term obligations.
STI has a Current ratio of 0.13. This is amonst the worse of the industry: STI underperforms 92.55% of its industry peers.
STI has a Quick Ratio of 0.13. This is a bad value and indicates that STI is not financially healthy enough and could expect problems in meeting its short term obligations.
STI has a Quick ratio of 0.13. This is amonst the worse of the industry: STI underperforms 92.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
STI Yearly Current Assets VS Current LiabilitesSTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

STI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.91%, which is quite impressive.
EPS 1Y (TTM)89.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

STI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STI Price Earnings VS Forward Price EarningsSTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STI Per share dataSTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

STI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLIDION TECHNOLOGY INC

NASDAQ:STI (6/10/2025, 8:10:12 PM)

After market: 3.4 -0.1 (-2.86%)

3.5

+0.01 (+0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.92%
Inst Owner Change-23.51%
Ins OwnersN/A
Ins Owner Change-0.25%
Market Cap9.52M
Analysts72.4
Price TargetN/A
Short Float %N/A
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.96
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)-2.71
OCFYN/A
SpS0
BVpS-8.42
TBVpS-9.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -325.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-117.72%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -29.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-278.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-177.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.25%
OCF growth 3YN/A
OCF growth 5YN/A